|

EMB-01 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: FIT-013a

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shanghai EpimAb Biotherapeutics Co., Ltd.1

Indications

  • Metastatic Gastrointestinal Carcinoid Tumor1
  • Neoplasms1
  • Neoplasm Metastasis1
  • Cancer1

Houston, Texas1 trial

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.